DaVita
DaVita
DVA
NYSE
143.31
USD
1.55%
About
DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis and related lab services (U.S. dialysis) business treats patients with chronic kidney failure, end-stage kidney disease (ESKD).
The Company’s robust platform delivers kidney care services and also includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States.
It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations..
Financials Amount (in millions)
Income statement
Balance sheet
Cash flow
Ratios
| Price and Volume | |
|---|---|
| Volume | |
| Ten Day Average Volume | 603.0K |
| Three Month Average Volume | 16.5M |
| High Low | |
| Fifty-Two Week High | 156.44 USD |
| Fifty-Two Week Low | 71.51 USD |
| Fifty-Two Week High Date | 26 Aug 2024 |
| Fifty-Two Week Low Date | 11 Oct 2023 |
| Price and Volume | |
| Current Price | 150.92 USD |
| Beta | 1 |
| Relative Price Change | |
| Four Week Relative Price Change | 2.39% |
| Thirteen Week Relative Price Change | -4.15% |
| Twenty-Six Week Relative Price Change | 8.15% |
| Fifty-Two Week Relative Price Change | 17.59% |
| Year-to-Date Relative Price Change | 21.65% |
| Price Change | |
| One Day Price Change | -1.51% |
| Thirteen Week Price Change | 2.58% |
| Twenty-Six Week Price Change | 18.91% |
| Five Day Price Change | -1.99% |
| Fifty-Two Week Price Change | 47.35% |
| Year-to-Date Price Change | 44.06% |
| Month-to-Date Price Change | 10.47% |
| Per Share Data | |
|---|---|
| Book Value | |
| Book Value Per Share (Last Fiscal Year) | 11.88977 USD |
| Book Value Per Share (Most Recent Quarter) | 7.43879 USD |
| Tangible Book Value Per Share (Last Fiscal Year) | -70.47292 USD |
| Tangible Book Value Per Share (Most Recent Quarter) | -79.45349 USD |
| EBITD | |
| EBITD Per Share (Trailing Twelve Months) | 29.20675 USD |
| Revenue | |
| Revenue Per Share (Last Fiscal Year) | 130.2843 USD |
| Revenue Per Share (Trailing Twelve Months) | 136.7605 USD |
| Dividend | |
| Dividend Per Share (Last Fiscal Year) | -99999.99 USD |
| Dividend Per Share (Trailing Twelve Months) | 0 USD |
| Dividend Per Share (5 Year) | -99999.99 USD |
| Earnings Per Share | |
| Excluding Extraordinary Items (Last Fiscal Year) | 7.42134 USD |
| Excluding Extraordinary Items (Trailing Twelve Months) | 9.39661 USD |
| Normalized (Last Fiscal Year) | 9.17543 USD |
| Basic Excluding Extraordinary Items (Last Fiscal Year) | 7.61686 USD |
| Basic Excluding Extraordinary Items (Trailing Twelve Months) | 9.66101 USD |
| Including Extraordinary Items (Last Fiscal Year) | 7.42134 USD |
| Including Extraordinary Items (Trailing Twelve Months) | 9.39661 USD |
| Cash | |
| Cash Per Share (Last Fiscal Year) | 4.40954 USD |
| Cash Per Share (Most Recent Quarter) | 5.13847 USD |
| Cash Flow Per Share (Last Fiscal Year) | 18.26985 USD |
| Cash Flow Per Share (Trailing Twelve Months) | 20.661 USD |
| Free Cash Flow Per Share (Trailing Twelve Months) | 13.85535 USD |
| Margins | |
|---|---|
| Cash Flow Revenue | |
| Cash Flow Revenue (5 Year) | 12 |
| Cash Flow Revenue (Trailing Twelve Months) | 10 |
| Pretax Margin | |
| Pretax Margin (Trailing Twelve Months) | 11.26% |
| Pretax Margin (Last Fiscal Year) | 9.70% |
| Pretax Margin (5 Year) | 10.59% |
| Gross Margin | |
| Gross Margin (Last Fiscal Year) | 31.47% |
| Gross Margin (Trailing Twelve Months) | 32.72% |
| Gross Margin (5 Year) | 30.70% |
| Operating Margin | |
| Operating Margin (Last Fiscal Year) | 13.14% |
| Operating Margin (Trailing Twelve Months) | 14.90% |
| Operating Margin (5 Year) | 13.63% |
| Net Profit Margin | |
| Net Profit Margin (Last Fiscal Year) | 7.88% |
| Net Profit Margin (Trailing Twelve Months) | 9.15% |
| Net Profit Margin (5 Year) | 8.33% |
| Growth | |
|---|---|
| Book Value | |
| Book Value Per Share (5 Year) | -11.79% |
| Tangible Book Value (5 Year) | -99,999.99% |
| Free Operating Cash Flow | |
| Free Operating Cash Flow (5 Year) | 22.36% |
| Revenue | |
| Revenue Change MRQ vs 1 Year Ago | 6.21% |
| Revenue Growth (3 Year) | 1.26% |
| Revenue Change (Trailing Twelve Months) | 6.69% |
| Revenue Per Share Growth | 14.51% |
| Revenue Growth (5 Year) | 1.67% |
| Capital Spending Debt | |
| Capital Spending (5 Year) | -10.47% |
| Total Debt (5 Year) | -3.64% |
| Dividends | |
| Dividend Growth (3 Year) | -99,999.99% |
| Earnings Per Share | |
| EPS Change MRQ vs 1 Year Ago | 30.87% |
| EPS Change (Trailing Twelve Months) | 92.29% |
| EPS Growth (3 Year) | 15.72% |
| EPS Growth (5 Year) | 5.13% |
| EBITDA | |
| EBITDA (5 Year) | 3.85% |
| EBITDA (5 Year Interim) | 4.87% |
| Net Profit Margin | |
| Net Profit Margin Growth (5 Year) | 2.62% |
| Valuation | |
|---|---|
| Total Price to Book | |
| Price to Tangible Book (Last Fiscal Year) | -100,000 |
| Price to Tangible Book (Most Recent Quarter) | -100,000 |
| Price to Free Cash Flow | |
| Price to Free Cash Per Share (Last Fiscal Year) | 8 |
| Price to Free Cash Per Share (Trailing Twelve Months) | 10 |
| Net Debt | |
| Net Debt (Most Recent Quarter) | 8.6B |
| Net Debt (Last Fiscal Year) | 8.0B |
| Price to Sales | |
| Price to Sales (Last Fiscal Year) | 1 |
| Price to Sales (Trailing Twelve Months) | 1 |
| Price to Earnings | |
| PE Excluding Extraordinary Items (Last Fiscal Year) | 16 |
| PE Normalized (Last Fiscal Year) | 16 |
| PE Basic Excluding Extraordinary Items (Trailing Twelve Months) | 14 |
| PE Excluding Extraordinary Items High (Trailing Twelve Months) | 21 |
| PE Excluding Extraordinary Items Low (Trailing Twelve Months) | 10 |
| PE Including Extraordinary Items (Trailing Twelve Months) | 16 |
| Dividends | |
| Dividend Yield (5 Year) | -99,999.99% |
| Dividend Yield | -99,999.99% |
| Current Dividend Yield | 0.00% |
| Price to Book | |
| Price to Book (Last Fiscal Year) | 13 |
| Price to Book (Most Recent Quarter) | 20 |
| Financial Strength | |
|---|---|
| Debt to Equity | |
| Long Term Debt to Equity (Last Fiscal Year) | 783 |
| Long Term Debt to Equity (Most Recent Quarter) | 1.3K |
| Payout Ratio | |
| Payout Ratio (Last Fiscal Year) | 0.00% |
| Payout Ratio (Trailing Twelve Months) | 0.00% |
| Quick Ratio | |
| Quick Ratio (Last Fiscal Year) | 1 |
| Quick Ratio (Most Recent Quarter) | 1 |
| Enterprise Value | |
| Current Enterprise Value to Free Cash Flow (Last Fiscal Year) | 20 |
| Current Enterprise Value to Free Cash Flow (Trailing Twelve Months) | 17 |
| Current Ratio | |
| Current Ratio (Last Fiscal Year) | 1 |
| Current Ratio (Most Recent Quarter) | 1 |
| Free Cash Flow | |
| Free Cash Flow (Last Fiscal Year) | 1.5B |
| Free Cash Flow (Trailing Twelve Months) | 1.3B |
| Net Interest Coverage | |
| Net Interest Coverage (Last Fiscal Year) | 5 |
| Net Interest Coverage (Trailing Twelve Months) | 5 |
| Total Debt to Equity | |
| Total Debt to Equity (Last Fiscal Year) | 795 |
| Total Debt to Equity (Most Recent Quarter) | 1.4K |
| Management Effectiveness | |
|---|---|
| Return on Assets | |
| Return on Assets (Last Fiscal Year) | 5.66% |
| Return on Assets (Trailing Twelve Months) | 6.74% |
| Return on Assets (5 Year) | 5.62% |
| Return on Equity | |
| Return on Equity (Last Fiscal Year) | 78.21% |
| Return on Equity (Trailing Twelve Months) | 104.17% |
| Return on Equity (5 Year) | 50.32% |
| Return on Investment | |
| Return on Investment (Last Fiscal Year) | 7.55% |
| Return on Investment (Trailing Twelve Months) | 9.10% |
| Return on Investment (5 Year) | 7.45% |